Skip to main content

Juan José Palmí Perales

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Juan José Palmí Perales

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Belen Alvarez Palomo

Belen Alvarez Palomo

Postdoctoral researcher
Transfusional Medicine
Read more
Ana Mª Moreno Perni

Ana Mª Moreno Perni

Research technician
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more
Zaira Ivette Castañeda Amado

Zaira Ivette Castañeda Amado

Predoctoral researcher
Nephrology and kidney transplantation
Read more
Daniel Sánchez-Tejerin San José

Daniel Sánchez-Tejerin San José

Predoctoral researcher
Peripheral Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.